Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MIKHAIL KOSIBOROD

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1588613657
CMS profile
26487
Location
KANSAS CITY, MO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$170,860.81

81 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MIKHAIL KOSIBOROD

NPI 1588613657 · CMS profile ID 26487

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

KANSAS CITY, MO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1588613657?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MIKHAIL KOSIBOROD, NPI 1588613657, CMS profile ID 26487. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1588613657?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). MIKHAIL KOSIBOROD, NPI 1588613657, CMS profile ID 26487. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1588613657?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
MIKHAIL KOSIBOROD, NPI 1588613657, CMS profile ID 26487, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1588613657?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

81 matching records · $170,860.81 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 81 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–81 of 81.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $900.0007/24/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050098515 CMS
AstraZeneca Pharmaceuticals LP $47.9806/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011794581 CMS
AstraZeneca Pharmaceuticals LP $63.0306/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011269521 CMS
SANOFI-AVENTIS U.S. LLC $54.8806/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049847315 CMS
Bayer Healthcare Pharmaceuticals Inc. $1,800.0006/14/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000427049 CMS
Novo Nordisk Inc $775.0005/31/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002657691 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.6205/26/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000409471 CMS
Novo Nordisk AS $93.5205/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006612227 CMS
Novo Nordisk AS $442.9205/22/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006612347 CMS
Novo Nordisk AS $639.2905/22/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006612363 CMS
Novo Nordisk AS $10,656.2505/22/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006616375 CMS
AstraZeneca Pharmaceuticals LP $18.6205/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016155875 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $9,180.0005/02/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996605885 CMS
Novo Nordisk Inc $118.2004/26/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002032951 CMS
Novo Nordisk Inc $329.9104/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002032971 CMS
Novo Nordisk Inc $629.4604/26/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002032991 CMS
Novo Nordisk Inc $14,143.7504/26/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002657717 CMS
Novo Nordisk Inc $1,550.0004/25/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002657705 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $140.0004/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996605889 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.0004/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996605893 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $159.8503/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996605877 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $1,578.1403/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997068879 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $8.5303/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997131387 CMS
AstraZeneca UK Limited $1,200.0003/14/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017036341 CMS
Boehringer Ingelheim International GmbH $67.8403/10/2023 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1155206556 CMS
Boehringer Ingelheim International GmbH $84.8003/10/2023 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1155206558 CMS
Boehringer Ingelheim International GmbH $386.1603/10/2023 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1155206560 CMS
Boehringer Ingelheim International GmbH $576.6503/10/2023 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1155206562 CMS
Boehringer Ingelheim International GmbH $8,233.6303/10/2023 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1155206564 CMS
Amgen Inc. $2,380.0002/17/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020032129 CMS
AstraZeneca AB $600.0001/03/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017063751 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $376,726.50 192
PY2020 $198,482.53 69
PY2021 $100,699.32 44
PY2022 $173,324.72 95
PY2023 $170,860.81 81
PY2024 $129,050.46 93
PY2025 $300.00 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $152,615.08 40
PY2024 Recipient $4,647.83 1
PY2024 Principal investigator $701,421.86 6
PY2023 Recipient $4,151.00 3
PY2023 Principal investigator $260,773.13 19
PY2022 Recipient $1,500.00 1
PY2022 Principal investigator $2,486,353.76 373
PY2021 Recipient $6,166.78 4
PY2021 Principal investigator $4,401,170.03 209
PY2020 Recipient $18,852.15 3
PY2020 Principal investigator $13,973,475.77 4
PY2019 Recipient $6,459.82 1
PY2019 Principal investigator $4,632,689.98 34

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

40 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $234.00 12/15/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419561
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,017.90 12/15/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
Finality Study #22618 No dispute reported 06/30/2026 1225420005
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $2,770.20 12/04/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
Confirmation Study #22563 No dispute reported 06/30/2026 1225420063
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $141.75 12/01/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
Confirmation Study #22563 No dispute reported 06/30/2026 1225420077
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $559.00 11/17/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419527
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $856.70 11/11/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
Finality Study #22618 No dispute reported 06/30/2026 1225420163
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $781.30 11/06/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419169
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $2,490.80 11/06/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
Finality Study #22618 No dispute reported 06/30/2026 1225419947
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,012.50 10/10/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
Confirmation Study #22563 No dispute reported 06/30/2026 1225419981
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,432.60 10/08/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419027
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $471.90 10/08/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
Finality Study #22618 No dispute reported 06/30/2026 1225419925
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $338.00 09/15/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419315
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $339.30 09/15/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
Finality Study #22618 No dispute reported 06/30/2026 1225420205
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $2,427.10 09/08/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225418993
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $390.00 09/08/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419151
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $422.50 09/08/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
Finality Study #22618 No dispute reported 06/30/2026 1225419905
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,302.60 09/08/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
Finality Study #22618 No dispute reported 06/30/2026 1225420117
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $339.30 08/25/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
Finality Study #22618 No dispute reported 06/30/2026 1225420175
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $338.00 08/20/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419517
Principal investigator 1 PFIZER INC. $49,704.83 08/13/2025 Covered Recipient Teaching Hospital
Saint Lukes Hospital Of Kansas City
RELATIONSHIP BETWEEN GDF15 LEVELS AND PATIENTS SYMPTOMS PHYSICAL LIMITATIONS AND QUALITY OF LIFE IN INDIVIDUALS WITH HEART FAILURE AND REDUCED EJECTION FRACTION No dispute reported 06/30/2026 1228708725
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $21,037.50 08/11/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
Confirmation Study #22563 No dispute reported 06/30/2026 1225420115
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $781.30 08/05/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419369
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $3,679.00 08/04/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
Finality Study #22618 No dispute reported 06/30/2026 1225420033
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $338.00 07/14/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419501
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,229.80 07/14/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
Finality Study #22618 No dispute reported 06/30/2026 1225420041
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $5,135.00 07/09/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419327
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $650.00 07/02/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419407
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $2,567.50 06/02/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419651
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $18,606.00 06/02/2025 Non-covered Recipient Entity
Norton Healthcare Cardiothoracic Surgeons Of Louisville
Confirmation Study #22563 No dispute reported 06/30/2026 1225419909
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $716.30 05/06/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419445
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $15,957.50 05/05/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
Finality Study #22618 No dispute reported 06/30/2026 1225420065
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $338.00 04/15/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419305
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $461.50 04/07/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419555
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $650.00 04/02/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419135
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $781.30 03/11/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419267
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $169.00 02/26/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419165
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,786.20 02/10/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419389
Principal investigator 1 Amgen Inc. $9,817.50 02/07/2025 Covered Recipient Teaching Hospital
Saint Lukes Hospital Of Kansas City
EVOLVE-MI: A Pragmatic Randomized Multicenter Trial of EVOLocumab administered Very Early to Reduce the Risk of Cardiovascular Events in patients hospitalized with Acute Myocardial Infarction No dispute reported 06/30/2026 1246637832
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $153.40 01/29/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419041
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $390.00 01/17/2025 Non-covered Recipient Entity
Methodist Medical Center Of Illinois
REDEFINE-HF Study #22438 No dispute reported 06/30/2026 1225419423